Physician profile
Mark David Oliver
NPI 1265520027
$37,894.55
in general payments reported to CMS, 2019-2025
15 companies · $74.21 in 2025
The $74.21 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $11K · 2022: $3,198 · 2023: $31.02 · 2025: $74.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $36,827.54 | 2019-2022 | |
| Orthofix Medical, INC. | $283.16 | 2019-2022 | |
| Boston Scientific Corporation | $143.17 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $125.14 | 2019-2022 | |
| Medtronic, INC. | $115.23 | 2021-2025 | Mazor X System |
| Depuy Synthes Sales INC. | $78.14 | 2019-2022 | |
| Surgalign Spine Technologies, INC. | $62.55 | 2019-2020 | |
| Abbott Laboratories | $59.94 | 2020-2022 | |
| Stryker Corporation | $55.36 | 2022 | |
| Smith+Nephew, INC. | $46.24 | 2020 | |
| 7d Surgical INC. | $44.97 | 2020 | |
| Ethicon US, LLC | $18.74 | 2020 | |
| Providence Medical Technology, INC. | $18.64 | 2019 | |
| Zimmer Biomet Holdings, INC. | $15.73 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$37,359,016.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.